Literature DB >> 15509792

The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.

Fei Gao1, Sourindra Maiti, Guizhi Sun, Nelson G Ordonez, Malini Udtha, Jian Min Deng, Richard R Behringer, Vicki Huff.   

Abstract

Renal failure is a frequent and costly complication of many chronic diseases, including diabetes and hypertension. One common feature of renal failure is glomerulosclerosis, the pathobiology of which is unclear. To help elucidate this, we generated a mouse strain carrying the missense mutation Wt1 R394W, which predisposes humans to glomerulosclerosis and early-onset renal failure (Denys-Drash syndrome [DDS]). Kidney development was normal in Wt1(+/R394W) heterozygotes. However, by 4 months of age 100% of male heterozygotes displayed proteinuria and glomerulosclerosis characteristic of DDS patients. This phenotype was observed in an MF1 background but not in a mixed B6/129 background, suggestive of the action of a strain-specific modifying gene(s). WT1 encodes a nuclear transcription factor, and the R394W mutation is known to impair this function. Therefore, to investigate the mechanism of Wt1 R394W-induced renal failure, the expression of genes whose deletion leads to glomerulosclerosis (NPHS1, NPHS2, and CD2AP) was quantitated. In mutant kidneys, NPHS1 and NPHS2 were only moderately downregulated (25 to 30%) at birth but not at 2 or 4 months. Expression of CD2AP was not changed at birth but was significantly upregulated at 2 and 4 months. Podocalyxin was downregulated by 20% in newborn kidneys but not in kidneys at later ages. Two other genes implicated in glomerulosclerosis, TGFB1 and IGF1, were upregulated at 2 months and at 2 and 4 months, respectively. It is not clear whether the significant alterations in gene expression are a cause or a consequence of the disease process. However, the data do suggest that Wt1 R394W-induced glomerulosclerosis may be independent of downregulation of the genes for NPHS1, NPHS2, CD2AP, and podocalyxin and may involve other genes yet to be implicated in renal failure. The Wt1(R394W) mouse recapitulates the pathology and disease progression observed in patients carrying the same mutation, and the mutation is completely penetrant in male animals. Thus, it will be a powerful and biologically relevant model for investigating the pathobiology of the earliest events in glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509792      PMCID: PMC525476          DOI: 10.1128/MCB.24.22.9899-9910.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus.

Authors:  M Iwano; A Kubo; T Nishino; H Sato; H Nishioka; Y Akai; H Kurioka; Y Fujii; M Kanauchi; H Shiiki; K Dohi
Journal:  Kidney Int       Date:  1996-04       Impact factor: 10.612

2.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

Authors:  N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

4.  Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.

Authors:  M W Nachtigal; Y Hirokawa; D L Enyeart-VanHouten; J N Flanagan; G D Hammer; H A Ingraham
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

5.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

6.  Low-protein diet suppresses serum insulin-like growth factor-1 and decelerates the progression of growth hormone-induced glomerulosclerosis.

Authors:  S Q Doi; S Rasaiah; I Tack; J Mysore; J J Kopchick; J Moore; P Hirszel; L J Striker; G E Striker
Journal:  Am J Nephrol       Date:  2001 Jul-Aug       Impact factor: 3.754

7.  The Wilms tumor suppressor gene wt1 is required for development of the spleen.

Authors:  U Herzer; A Crocoll; D Barton; N Howells; C Englert
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

8.  Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

Authors:  Y Isaka; Y Fujiwara; N Ueda; Y Kaneda; T Kamada; E Imai
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.

Authors:  Malini Udtha; Sang-Joon Lee; Rita Alam; Kevin Coombes; Vicki Huff
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

10.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  21 in total

Review 1.  Educational paper: the podocytopathies.

Authors:  Anja K Büscher; Stefanie Weber
Journal:  Eur J Pediatr       Date:  2012-01-13       Impact factor: 3.183

2.  The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis.

Authors:  Fei Gao; Sourindra Maiti; Nargis Alam; Zhen Zhang; Jian Min Deng; Richard R Behringer; Charlotte Lécureuil; Florian Guillou; Vicki Huff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

3.  A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.

Authors:  Gentzon Hall; Rasheed A Gbadegesin; Peter Lavin; Guanghong Wu; Yangfan Liu; Edwin C Oh; Liming Wang; Robert F Spurney; Jason Eckel; Thomas Lindsey; Alison Homstad; Andrew F Malone; Paul J Phelan; Andrey Shaw; David N Howell; Peter J Conlon; Nicholas Katsanis; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

4.  Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.

Authors:  Jutta Gellermann; Constantinos J Stefanidis; Andromachi Mitsioni; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2010-02-27       Impact factor: 3.714

5.  A familial WT1 mutation associated with incomplete Denys-Drash syndrome.

Authors:  Chunhua Zhu; Fei Zhao; Weizhen Zhang; Hongmei Wu; Ying Chen; Guixia Ding; Aihua Zhang; Songming Huang
Journal:  Eur J Pediatr       Date:  2013-05-29       Impact factor: 3.183

Review 6.  Molecular genetics of Müllerian duct formation, regression and differentiation.

Authors:  Rachel D Mullen; Richard R Behringer
Journal:  Sex Dev       Date:  2014-07-12       Impact factor: 1.824

7.  Ectopic notch activation in developing podocytes causes glomerulosclerosis.

Authors:  Aoife M Waters; Megan Y J Wu; Tuncer Onay; Jacob Scutaru; Ju Liu; Corrinne G Lobe; Susan E Quaggin; Tino D Piscione
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

8.  Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture.

Authors:  Laura A New; Claire E Martin; Rizaldy P Scott; Mathew J Platt; Ava Keyvani Chahi; Colin D Stringer; Peihua Lu; Bozena Samborska; Vera Eremina; Tomoko Takano; Jeremy A Simpson; Susan E Quaggin; Nina Jones
Journal:  J Am Soc Nephrol       Date:  2016-01-22       Impact factor: 10.121

9.  Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).

Authors:  Charles E Patek; David G Brownstein; Stewart Fleming; Caroline Wroe; Lorraine Rose; Anna Webb; Rachel L Berry; Paul S Devenney; Marion Walker; Oliver D K Maddocks; Nicola J Lawrence; David J Harrison; Katrina M Wood; Colin G Miles; Martin L Hooper
Journal:  Transgenic Res       Date:  2007-11-27       Impact factor: 2.788

Review 10.  Wt1 in the kidney--a tale in mouse models.

Authors:  Derya Deniz Ozdemir; Peter Hohenstein
Journal:  Pediatr Nephrol       Date:  2013-11-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.